Kathryn J. Collier

Insider Reports History

Location
San Diego, CA
Signature
/s/ Christopher Aker, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kathryn J. Collier:

Company Role Class Num Shares Value Price $ Report Date Ownership
Regulus Therapeutics Inc. Director Common Stock 0 $0 $7.87 25 Jun 2025 Direct
Regulus Therapeutics Inc. Director Stock Option 0 25 Jun 2025 Direct
Regulus Therapeutics Inc. Director Stock Option (Right to Buy) 0 17 Jun 2025 Direct

Insider Reports Filed by Kathryn J. Collier

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RGLS Regulus Therapeutics Inc. 25 Jun 2025 7 $0 4 Director 27 Jun 2025, 17:00
RGLS Regulus Therapeutics Inc. 16 Jun 2025 6 +$60,060 4 Director 18 Jun 2025, 17:00
RGLS Regulus Therapeutics Inc. 30 Apr 2025 1 $0 4 Director 30 Apr 2025, 16:30
RGLS Regulus Therapeutics Inc. 25 Jul 2024 1 +$7,280 4 Director 29 Jul 2024, 16:18
RGLS Regulus Therapeutics Inc. 20 May 2024 1 $0 4 Director 21 May 2024, 16:22
RGLS Regulus Therapeutics Inc. 16 May 2024 1 $0 4 Director 17 May 2024, 17:16
RGLS Regulus Therapeutics Inc. 10 Aug 2023 1 $0 4 Director 14 Aug 2023, 17:40
RGLS Regulus Therapeutics Inc. 13 Jun 2023 1 $0 4 Director 13 Jun 2023, 16:47
RGLS Regulus Therapeutics Inc. 09 Jun 2022 1 $0 4 Director 10 Jun 2022, 16:24
RGLS Regulus Therapeutics Inc. 14 Jun 2021 1 $0 4 Director 15 Jun 2021, 16:40